Methods and compositions for enhancing the bioadhesive properties of polymers using organic excipients

• US 5,955,096 A
• Filed: 06/25/1996
• Issued: 09/21/1999
• Est. Priority Date: 06/25/1996
• Status: Expired due to Term

• Current Assignee: Perosphere Inc.
• Original Assignee: Brown University
• Inventors: Mathiowitz, Edith, Jacob, Jules S., Hertzog, Benjamin A., Carino, Gerardo P., Santos, Camila A.
• Primary Examiner(s): YOON, TAE H
• Application Number:
  US08/670,326
• Time in Patent Office: 1,183 Days
• Field of Search: 424/434, 424/491, 424/498, 528/271, 523/105, 523/113, 525/419
• US Class Current: 424/434
• CPC Class Codes: A61K 9/1641 obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
• CPC Class Codes: A61K 9/1647 Polyesters, e.g. poly(lactide-co-glycolide)
• CPC Class Codes: A61K 9/5138 obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
• CPC Class Codes: A61K 9/5153 Polyesters, e.g. poly(lactide-co-glycolide)

Abstract

Methods and compositions are provided for enhancing the bioadhesive properties of polymers used in drug delivery systems. The bioadhesive properties of a polymer are enhanced by incorporating an anhydride oligomer into the polymer to enhance the ability of the polymer to adhere to a tissue surface such as a mucosal membrane. Anhydride oligomers which enhance the bioadhesive properties of a polymer include oligomers synthesized from dicarboxylic acid monomers, preferably those found in Krebs glycolysis cycle, especially fumaric acid. The oligomers can be incorporated within a wide range of polymers including proteins, polysaccharides and synthetic biocompatible polymers. In one embodiment, anhydride oligomers can be incorporated within polymers used to form or coat drug delivery systems, such as microspheres, which contain a drug or diagnostic agent. The oligomers can either be solubilized and blended with the polymer before manufacture or else used as a coating with polymers over existing systems. The polymers, for example in the form of microspheres, have improved ability to adhere to mucosal membranes, and thus can be used to deliver a drug or diagnostic agent via any of a range of mucosal membrane surfaces including those of the gastrointestinal, respiratory, excretory and reproductive tracts.

Claims

1. A method for improving the bioadhesiveness of a polymer, the method comprising incorporating an anhydride oligomer in the polymer in an amount effective to enhance the ability of the polymer to adhere to a mucosal membrane, wherein the anhydride oligomer includes twenty or fewer diacid units linked by anhydride linkages or has a molecular weight of 5000 Daltons or less, and wherein the anhydride oligomer is incorporated by dispersing solid particles of anhydride oligomer into the polymer, dissolving anhydride oligomer and polymer in a solvent for both the polymer and the oligomer, or blending liquified anhydride oligomer with liquified polymer.

2. The method of claim 1 wherein the anhydride oligomer is associated with the polymer by ionic or covalent bonds.

3. The method of claim 1 wherein the anhydride oligomer comprises dicarboxylic acid monomers selected from the group consisting of fumaric, maleic, succinic, adipic, sebacic and carboxyphenolic acids.

4. The method of claim 1 wherein the anhydride oligomer comprises dicarboxylic acid monomers selected from the group consisting of bis(p-carboxyphenoxy)methane, bis(p-carboxyphenoxy)propane, and bis(p-carboxyphenoxy)hexane, phthalic acid, isophthalic acid, terephthalic acid, azeleic acid, pimelic acid, itaconic acid, cyclohexane dicarboxylic acid, 1,4 phenylene dipropionic acid and 1,10-dodecanedioic acid.

5. The method of claim 1 wherein the polymer is in the form of a microsphere, and wherein the method comprises improving the bioadhesiveness of the microsphere by incorporating the anhydride oligomer in the polymer during formation of the microsphere, thereby to enhance the ability of the microsphere to adhere to a mucosal membrane.

6. The method of claim 5 wherein the anhydride oligomer is in the form of a fine dispersion of particles on at least the surface of the microsphere.

7. The method of claim 5 wherein the polymer incorporating the anhydride oligomer is coated onto the surface of a microsphere formed of a different material.

8. The method of claim 1 wherein the polymer is selected from the group consisting of proteins and polysaccharides.

9. The method of claim 1 wherein the polymer is selected from the group consisting of polyamides, polycarbonates, polyalkylenes, polyaryalkylenes, polyalkylene glycols, polyalkylene oxides, polyalkylene terephthalates, polyvinyl polymers, polyphosphazenes, polyacrylamides, polysiloxanes, polyurethanes, polymers of acrylic and methacrylic acid, celluloses, polyanhydrides, polyesters, poly(hydroxy acids), and blends and copolymers thereof.

10. The method of claim 5 wherein the microsphere further comprises a therapeutic or diagnostic agent.

11. The method of claim 10 wherein the diagnostic agent is selected from the group consisting of gases, gas evolving agents and radio-opaque compounds.

12. The method of claim 1 wherein the polymer defines or coats a drug delivery device containing a therapeutic agent.

13. The method of claim 1 wherein the polymer defines or coats a surgical implant device.

14. The method of claim 5 wherein the microsphere has a diameter greater than or equal to about 10 microns.

15. The method of claim 5 wherein the microsphere has a diameter between about 2 and 5 microns.

16. The method of claim 5 wherein the microsphere has a diameter of less than about 2 microns.

17. The method of claim 5 wherein the microsphere has a diameter less than about 1 micron.

18. A composition comprising a polymer incorporating an anhydride oligomer in an amount effective to improve adhesion of the polymer to a mucosal membrane, wherein the anhydride oligomer includes twenty or fewer diacid units linked by anhydride linkages or has a molecular weight of 5000 Daltons or less, and wherein the anhydride oligomer is incorporated by dispersing solid particles of anhydride oligomer into the polymer, dissolving anhydride oligomer and polymer in a solvent for both the polymer and the oligomer, or blending liquified anhydride oligomer with liquified polymer.

19. The composition of claim 18 wherein the anhydride oligomer is associated with the polymer by ionic interactions or covalent bonds.

20. The composition of claim 18 wherein the anhydride oligomer comprises dicarboxylic acid monomers selected from the group consisting of fumaric, maleic, succinic, adipic, sebacic and carboxyphenolic acids.

21. The composition of claim 18 wherein the polymer is in the form of a microsphere.

22. The composition of claim 21 wherein the anhydride oligomer is in the form of a fine dispersion of particles on at least the surface of the microsphere.

23. The composition of claim 21 wherein the polymer incorporating the anhydride oligomer is coated onto the surface of a microsphere formed of a different material.

24. The composition of claim 18 wherein the polymer is selected from the group consisting of proteins and polysaccharides.

25. The composition of claim 18 wherein the polymer is selected from the group consisting of polyamides, polycarbonates, polyalkylenes, polyaryalkylenes, polyalkylene glycols, polyalkylene oxides, polyalkylene terephthalates, polyvinyl polymers, polyphosphazenes, polyacrylamides, polysiloxanes, polyurethanes, polymers of acrylic and methacrylic acid, celluloses, polyanhydrides, polyesters, poly(hydroxy acids), and blends and copolymers thereof.

26. The composition of claim 21 wherein the microsphere further comprises a therapeutic or diagnostic agent.

27. The composition of claim 26 wherein the diagnostic agent is selected from the group consisting of gases, gas evolving agents and radio-opaque compounds.

28. The composition of claim 18 wherein the polymer defines or coats a drug delivery device containing a therapeutic agent.

29. The composition of claim 21 wherein the microsphere has a diameter greater than or equal to about 10 microns.

30. The composition of claim 21 wherein the microsphere has a diameter of between about 2 to 5 microns.

31. The composition of claim 21 wherein the microsphere has a diameter less than about 2 microns.

32. The composition of claim 21 wherein the microsphere has a diameter less than about 1 micron.